About Genefluidics
Genefluidics is a company based in Irwindale (United States) founded in 2000. Genefluidics operates in a competitive market with competitors including Bright Uro, DNC Biotechnology, Clinical Design, Stream DX and COBIO Smart Healthcare Technology, among others.
- Headquarter Irwindale, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$4.61 M (USD), Grant
May 01, 2015
-
Investors
UCLA
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Genefluidics
Investors in Genefluidics
Genefluidics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include UCLA and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Undergraduate and postgraduate courses are offered across diversified streams.
|
Locked | Locked | Locked |
Investor details for Genefluidics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genefluidics
Investment portfolio details for Genefluidics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genefluidics
Detailed financials for Genefluidics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genefluidics Comparisons
Peer comparison for Genefluidics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genefluidics
Genefluidics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bright Uro, DNC Biotechnology, Clinical Design, Stream DX and COBIO Smart Healthcare Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Diagnostic devices for lower urinary tract diseases are developed.
|
|
| Locked | Locked | Locked |
In vitro diagnostic devices for urine infection detection are developed.
|
|
| Locked | Locked | Locked |
A patented urine diagnostic device for ten parameters is developed.
|
|
| Locked | Locked | Locked |
Uro-flow meters for LUTS diagnosis and patient care are provided.
|
|
| Locked | Locked | Locked |
High-throughput clinical analyzers, microscopes, and glucometers are developed and manufactured.
|
|
| Locked | Locked | Locked |
Provides DIY test kits for benign prostatic hyperplasia (BPH).
|
Detailed competitors of Genefluidics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genefluidics
Complete news archive for Genefluidics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genefluidics
Genefluidics was founded in 2000 and raised its 1st funding round 4 years after it was founded.
Genefluidics is headquartered in Irwindale, United States. It is registered at Irwindale, California, United States.
GeneFluidics is a biomedical diagnostics company engaged in the development of rapid tests for detection of direct bloodstream infection (BSI), pathogen identification (PID) and antimicrobial susceptibility tests (AST). The company has integrated the concepts of bio-nano, microfluidic technologies and its proprietary electrochemical sensor to develop a molecular analysis platform that allows users to perform rapid immunoassays and genetic assays with sensitivity to picogramml and femtomolar concentrations, respectively. The company has developed a modular robotic system-Proteus, the multi-channel microfluidics cartridge system-Asklepios, and sensor chip arrays. The Proteus Robotic System allows quantification of multiple proteins, nucleic acids and small molecules simultaneously. The company plans to complete the clinical testing for CE marking for Proteus lab automation system, allows rapid PID and AST of urinary tract infections (UTIs) by 2016.
Genefluidics's top competitors include Bright Uro, DNC Biotechnology and Clinical Design.